OP
OPCH.US Option Care Health Inc
- Market cap
- USD 4.75B
- P/E
- 23.0x
- P/B
- 3.58x
- ROE
- 15.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is OPCH.US undervalued?
Graham numberOPCH.US trades 91.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Option Care Health Inc fundamental analysis
No fundamental analysis for Option Care Health Inc yet.
Option Care Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory…
Full company profileOption Care Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Option Care Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 936M | 817M | 1.94B | 2.31B | 3.03B | 3.44B | 3.94B | 4.30B | 5.00B | 5.65B | 5.72B |
| Gross Profit | 262M | 269M | 422M | 513M | 682M | 780M | 867M | 981M | 1.01B | 1.02B | 1.07B |
| Operating Income | -36.2M | -63.3M | 38.3M | -319K | 111M | 191M | 240M | 315M | 322M | 338M | 335M |
| EBITDA | 53.5M | 66.3M | 78.1M | 53.4M | 180M | 252M | 325M | 472M | 396M | 417M | 409M |
| Net Income | -42.8M | -64.2M | -6.12M | -75.9M | -8.08M | 140M | 151M | 267M | 212M | 208M | 209M |
| EPS | -0.36 | -0.41 | -0.04 | -0.49 | -0.04 | 0.77 | 0.83 | 1.48 | 1.23 | 1.27 | 1.39 |
| Balance Sheet | |||||||||||
| Total Assets | 608M | 606M | 584M | 2.59B | 2.65B | 2.79B | 3.23B | 3.33B | 3.42B | 3.46B | 3.48B |
| Total Liabilities | 639M | 687M | 728M | 1.68B | 1.63B | 1.62B | 1.85B | 1.91B | 2.02B | 2.13B | 2.15B |
| Shareholders' Equity | -31.6M | -81.1M | -144M | 907M | 1.02B | 1.18B | 1.39B | 1.42B | 1.40B | 1.33B | 1.32B |
| Cash & Short-term Investments | 9.57M | 39.5M | 14.5M | 67.1M | 99.3M | 119M | 294M | 344M | 413M | 233M | 299M |
| Total Debt | 452M | 481M | 505M | 1.31B | 1.14B | 1.08B | 1.16B | 1.17B | 1.22B | 1.27B | 1.26B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -35.2M | -1.05M | -20.1M | 39.5M | 127M | 209M | 268M | 371M | 323M | 258M | 382M |
| Capital Expenditure | 9.64M | 8.39M | 13.9M | 28.3M | 26.9M | 25.6M | 35.4M | 41.9M | 35.6M | 41.3M | 35.7M |
| Free Cash Flow | -44.8M | -9.44M | -34.0M | 11.2M | 101M | 183M | 232M | 329M | 288M | 217M | 346M |
| Ratios | |||||||||||
| ROE | - | - | - | -8.4% | -0.8% | 11.9% | 10.9% | 18.8% | 15.1% | 15.7% | 15.8% |
| ROA | -7.0% | -10.6% | -1.0% | -2.9% | -0.3% | 5.0% | 4.7% | 8.0% | 6.2% | 6.0% | 6.0% |
| Net Profit Margin | -4.6% | -7.9% | -0.3% | -3.3% | -0.3% | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% | 3.7% |
| Debt to Equity | - | - | - | 1.44x | 1.13x | 0.92x | 0.83x | 0.82x | 0.87x | 0.96x | 0.95x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Option Care Health Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 904K | 0.00 | - |
| 2019 | USD 2.00M | 0.01 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:4 on Feb 3, 2020.
Who owns Option Care Health Inc
- Insiders 1.63%
- Institutions 98.37%
- Public & others 0.00%
- Shares outstanding 150M
- Free float 148M
Top funds holding OPCH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| FullerThaler Behavioral Sm-Cp Eq R6 | 7.16M | 4.78% | +5.17% | Jun 2026 |
| iShares Core S&P Mid-Cap ETF | 5.38M | 3.59% | +0.05% | Oct 2026 |
| Vanguard Health Care Inv | 4.83M | 3.22% | -33.70% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.78M | 3.19% | -4.28% | Sep 2026 |
| iShares Russell 2000 ETF | 4.05M | 2.70% | 0.00% | Oct 2026 |
| Vanguard Small Cap Index | 3.37M | 2.25% | -6.78% | Sep 2026 |
| Vanguard Explorer Inv | 2.64M | 1.77% | +21.24% | Sep 2026 |
| Fidelity Small Cap Index | 1.75M | 1.17% | +0.16% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 1.22M | 0.82% | -0.38% | Oct 2026 |
| DFA U.S. Targeted Value I | 1.13M | 0.76% | +12.43% | Sep 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 1.11M | 0.74% | -3.56% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 1.10M | 0.73% | 0.00% | Sep 2026 |
| Touchstone Small Company A | 1.07M | 0.72% | +5.26% | Sep 2026 |
| JHancock Small Cap Core NAV | 1.07M | 0.71% | 0.00% | Sep 2026 |
| Fidelity Enhanced Small Cap Core ETF | 1.06M | 0.71% | +0.27% | Oct 2026 |
| Value Intelligence ESG Fonds AMI I | 993K | 0.66% | 0.00% | Jul 2026 |
| Vanguard MStar Small Cap Growth Indx Inv | 938K | 0.63% | -54.84% | Sep 2026 |
| Vanguard Russell 2000 ETF | 928K | 0.62% | +1.14% | Sep 2026 |
| DFA U.S. Small Cap I | 926K | 0.62% | 0.00% | Sep 2026 |
| Dimensional US Targeted Value ETF | 910K | 0.61% | +0.03% | Oct 2026 |
Top institutions holding OPCH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 22.1M | 14.76% | +11.15% | Jun 2026 |
| Wellington Management Company LLP | 11.8M | 7.87% | -0.97% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 8.27M | 5.52% | +2.63% | Jun 2026 |
| Fuller & Thaler Asset Management Inc | 7.45M | 4.97% | +4.57% | Jun 2026 |
| Vanguard Capital Management, LLC | 7.06M | 4.72% | +0.68% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 6.31M | 4.21% | +15.79% | Sep 2026 |
| Durable Capital Partners LP | 6.16M | 4.11% | -31.45% | Jun 2026 |
| State Street Corp | 6.14M | 4.10% | +4.51% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 5.98M | 3.99% | +41.17% | Jun 2026 |
| Geode Capital Management, LLC | 4.47M | 2.98% | +5.17% | Jun 2026 |
| Millennium Management LLC | 2.62M | 1.75% | +59.59% | Jun 2026 |
| Van Berkom and Associates Inc | 2.58M | 1.72% | +18.18% | Sep 2026 |
| Charles Schwab Investment Management Inc | 2.46M | 1.65% | -0.97% | Jun 2026 |
| Bank of America Corp | 2.27M | 1.51% | +16.55% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.24M | 1.50% | -20.38% | Jun 2026 |
| The Goldman Sachs Group Inc | 2.17M | 1.45% | +57.60% | Jun 2026 |
| Sumitomo Mitsui Trust Group Inc | 2.13M | 1.42% | -18.32% | Jun 2026 |
| Northern Trust Corp | 1.96M | 1.31% | +0.85% | Jun 2026 |
| Boston Partners Global Investors, Inc | 1.95M | 1.30% | -19.71% | Jun 2026 |
| Nuveen, LLC | 1.94M | 1.29% | +19.62% | Jun 2026 |
Option Care Health Inc company profile
- Company name
- Option Care Health Inc
- Ticker
- OPCH.US
- Exchange
- USA Stocks
- Listed since
- Aug 15, 1996
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 6,528
- Fiscal year end
- December
- Address
- 3000 Lakeside Drive, Bannockburn, IL, United States, 60015
- Phone
- 312 940 2443
- Website
- optioncarehealth.com
About Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Option Care Health Inc management
10- Mr. John Charles RademacherCEO, President & Director · born 1967
- Mr. Luke WhitworthChief Operating Officer · born 1981
- Mr. Collin G. SmyserGeneral Counsel & Corporate Secretary · born 1979
- Ms. Nicole MaggioSenior VP, Controller & Principal Accounting Officer · born 1983
- Mr. Brett MichalakChief Technology Officer
- Ms. Alyssa MoyChief Information Officer
- Ms. Stacey MahoneSenior VP & Chief Compliance Officer
- Mr. Jorge RamirezSenior VP of Strategy and Corporate Development
- Mr. Michael BavaroChief Human Resources & Chief Diversity Officer · born 1978
- Dr. Femi Adewunmi M.D.Chief Medical Officer · born 1974